RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RICCI A
Collezione AOU San Luigi di Orbassano

Items : 5

Modern Stereotactic Radiotherapy for Brain Metastases from Lung Cancer: Current Trends and Future Perspectives Based on Integrated Translational Approaches. in Cancers / Cancers (Basel). 2023 Sep 18;15(18):4622. doi: 10.3390/cancers15184622.

2023
AOU San Luigi di Orbassano

Bertero L; Cassoni P; Ricardi U; Ricci AA; Mangherini L; Bironzo P; Mantovani C; De Giorgi G; Gastino A; Levis M;

Gamma camera calibrations for the Italian multicentre study for lesion dosimetry in (223)Ra therapy of bone metastases. in Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) / Phys Med. 2017 Sep;41:117-123. doi: 10.1016/j.ejmp.2017.04.019. Epub 2017 Apr 28.

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ricci A; Reggioli V; Fulcheri C; Cesana P; Virotta G; Carbonini C; Bianchi C; Cremonesi M; Ferrari M; Giancola S; Mango L; Ventroni G; De Vincentis G; Zorz A; Di Castro E; Pellegrini R; Cassano B; Pacilio M; Trevisiol E; Anglesio S; Pani R; Pacilio M; Cassano B; Pellegrini R; Di Castro E; Zorz A; De Vincentis G; Ventroni G; Mango L; et alii...

Neutralizing antibodies in multiple sclerosis patients treated with 375 micrograms interferon-beta-1b. in Expert opinion on biological therapy / Expert Opin Biol Ther. 2009 Apr;9(4):387-97. doi: 10.1517/14712590902762781.

2009
AOU San Luigi di Orbassano

Durelli L; Barbero P; Cucci A; Ferrero B; Ricci A; Contessa G; De Mercanti S; Ripellino P; Lapuma D; Viglietta E; Bergui M; Versino E; Clerico M;

Anti-interferon antibodies in multiple sclerosis. Molecular basis and their impact on clinical efficacy. in Frontiers in bioscience : a journal and virtual library / Front Biosci. 2004 Sep 1;9:2192-204. doi: 10.2741/1329.

2004
AOU San Luigi di Orbassano

Durelli L; Ricci A;

High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study. in Journal of the neurological sciences / J Neurol Sci. 2004 Jul 15;222(1-2):13-9. doi: 10.1016/j.jns.2004.03.023.

2004
AOU San Luigi di Orbassano

Barbero P; Verdun E; Bergui M; Pipieri A; Clerico M; Cucci A; Ricci A; Bergamasco B; Durelli L;